Quantitative correlation of spectroscopic signatures with ligand–protein interactions in anti-cancer drug Afinitor: an integrated experimental–computational study
Open Access
- 23 July 2026
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1) , 23078
Abstract
No abstract availableKeywords
Funding Information
- Manipal University Jaipur
This publication has 43 references indexed in Scilit:
- Advances in nanoparticle-mediated cancer therapeutics: Current research and future perspectivesCancer Pathogenesis and Therapy, 2024
- Cheminformatic evaluation of the multi-protein binding potential of some diselenide derivatives: A plausible drug discovery approach for leishmaniasisDiscover Chemistry, 2024
- Evaluation of dimedone-derived compounds as inhibitors against human colon cancer: Insights from 2D-QSAR, ADMET prediction, Osiris, Molinspiration, and molecular modelingChinese Journal of Analytical Chemistry, 2023
- Experimental spectroscopic and molecular docking investigations of the anticancer drugs aprepitant and capecitabineTheoretical Chemistry Accounts, 2023
- Computational insights into binding mechanism of drugs as potential inhibitors against SARS-CoV-2 targetsChemical Papers, 2021
- Identification and characterisation of putative drug binding sites in human ATP-binding cassette B5 (ABCB5) transporterComputational and Structural Biotechnology Journal, 2021
- Cancer of the Kidney2019
- Pharmacology and Molecular Mechanisms of Antineoplastic Agents for Hematologic Malignancies2018
- Finding off‐targets, biological pathways, and target diseases for chymase inhibitors via structure‐based systems biology approachProteins: Structure, Function, and Bioinformatics, 2014
- Everolimus2008